Beximco and Mylan’s licensing deal for biosimilar in Bangladesh
Posted on28 Feb 2020
TagsBeximco Pharmaceuticals, licensing deal in pharma, Mylan, mylan licensing deal, Ogivri, trastuzumab
Comments0
Under the terms of the agreement, Beximco Pharma will receive the exclusive rights to launch Mylan’s portfolio of key monoclonal antibodies to... Read More
Beximico Pharma Extends Reach into Gulf Market
Beximco Pharmaceuticals Limited, a fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, has commenced the export of pharmaceuticals to Kuwait. ... Read More